QuantaMatrix recorded the upper limit on the 14th after being selected for a government research project.
As of 9:08 a.m. on that day, QuantaMatrix recorded an upper limit at 4,550 won, up 1,050 won (30.00%) from the previous transaction.
QuantaMatrix announced that it has been finally selected for the '2025 Bioindustry Technology Development (R&D) Project' organized by the Ministry of Trade, Industry and Energy and the Korea Planning & Evaluation Institute of Industrial Technology (KEIT) on the 11th. The total research cost is about 7.1 billion won, of which 5.7 billion won will be supported by the government. The selected project is the development of a multimodal point-of-care diagnostic system for the rapid identification of infectious bacteria and evaluation of antibiotic susceptibility, with QuantaMatrix as the lead organization.
QuantaMatrix expects that this technology will dramatically shorten the existing testing time, which averages 3 to 4 days, enabling early treatment of sepsis patients.